FDA approves Merck combination cholesterol lowering pill
(Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Atorvastatin Calcium | Cholesterol | Food and Drug Administration (FDA) | Health | Lipitor | Merck | Pfizer | Statin Therapy | Zetia | Zivast